Our Staff
Director
Lim Lay Ah Young
Leverages knowledge of many international studies of new cancer therapies and determines treatment strategies together with Dr. Hijikata.
Brief Profile
| 2014 | Joined Chiba Cancer Center |
| 2016 | Joined the Institute of Medical Science, the University of Tokyo Hospital |
Qualifications
- Fellow of the Japanese Society of Internal Medicine
- General Clinical Oncologist (by JBCT)
- Clinical Pharmacology and Therapeutics Specialist
Medical doctor
Yasuki Hijikata
Treats patients in practice and is engaged in clinical research/studies of latest cancer treatments.
Served as a project leader in a clinical research; in charge of all processes such as culturing immune cells, administering them to cancer patients, and following them up.
Is a rare doctor specialized in both researches on immune cell culture technologies and other fields as well as clinical practice.
Also actively presented research results on cancer treatments at academic conferences in and outside Japan, and published many articles in international medical journals.
Brief Profile
| 2013 | Lecturer, Department of Advanced Molecular and Cell Therapy, Kyushu University Hospital |
| 2014 | Director, Department of Advanced Molecular and Cell Therapy, Kyushu University Hospital |
| 2016 | Assistant professor, Department of Advanced Medical Science, the Institute of Medical Science, the University of Tokyo Hospital |
| 2020 | Lecturer, Department of Palliative Medicine/Advanced Clinical Oncology, the Institute of Medical Science, the University of Tokyo Hospital |
Qualifications
- Fellow of the Japanese Society of Internal Medicine
- Supervisory doctor for trainees certified by the Japanese Society of Internal Medicine
- General Clinical Oncologist (by JBCT)
- Board certified physician for regenerative medicine
- Industrial physician certified by the Japan Medical Association
Articles
Medical doctor
Yasunori Ota
Analyzes cancer from the pathological and molecular viewpoints by examining the cancer tissues, tumor microenvironment, and infiltrating immune cells, and determines treatment strategies together with Dr. Hijikata.
Engages in advanced research on overall oncology including solid tumors and hematopoietic tumors, as well as on regenerative medicine and pathological diagnosis of infections; presented results in leading global journals such as Nature, Science, and Blood.
Brief Profile
| 2000 | Graduated from the Faculty of Medicine, The University of Tokyo |
| 2004 | Acquired the degree of Doctor of Medical Science, Graduate School of Medicine, The University of Tokyo |
| 2004〜2005 | Assistant, Human Pathology/Pathological Diagnosis, The University of Tokyo Hospital |
| 2005〜2013 | Chief physician, Division of Pathology, Toranomon Hospital |
| 2013〜2018 | Associate professor, Head, Department of Pathology, The Institute of Medical Science, the University of Tokyo Hospital |
Qualifications
- Certified pathologist of the Japanese Society of Pathology
- Supervisory physician certified by the Japanese Society of Clinical Cytology
- Pathologist certified by the Japanese Society of Clinical Cytology
Articles
Medical doctor
Asuka Inoue
Specializes in immunology and has abundant clinical experience in immune diseases. Familiar with measures against side effects, such as use of immune checkpoint inhibitors, etc.
Brief Profile
| 2010 | Graduated from the Faculty of Medicine, Kindai University |
| 2012 | Assistant professor, Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University |
| 2019 | Assistant professor, Department of Rheumatology, Kindai University Nara Hospital |
Qualifications
- Fellow of the Japanese Society of Internal Medicine
- Board certified member of the Japanese Society of Internal Medicine
- Rheumatologist certified by the Japan College of Rheumatology
- Supervisory rheumatologist certified by the Japan College of Rheumatology
Medical doctor
Narikazu Boku
Genomic analysis method
Yusuke Nakamura
Our clinic is working to promote precision medicine with the cooperation of Dr. Yusuke Nakamura and others.
Director, Cancer Precision Medicine Center, and Professor Emeritus of the University of Tokyo
Previously served as professor of the Institute of Medical Science, the University of Tokyo; director of the Human Genome Center at the Institute of Medical Science, the University of Tokyo; special advisor to the cabinet, and director, Medical Innovation Promotion Office at Cabinet Secretariat, Government of Japan; and professor of Department of Medicine, University of Chicago
Holds “tailored medicine” as the principle and as the world’s leading expert in cancer genomic medicine and cancer immunotherapy.
Won “Clarivate Analytics Citations Award” in 2020, which honors achievements of the world’s top tier researchers